Centeon Pharma GmbH.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Centeon Pharma GmbH..The latest application filed is for "novel adenoviral vector for transferring human genes in vivo".
- Centeon Pharma GmbH. -
- Centeon Pharma GmbH - Marburg DE
Trademarks
| Patent | Date |
|---|---|
| Novel adenoviral vector for transferring human genes in vivo App 20030212030 - Poller, Wolfgang Christian | 2003-11-13 |
| Stabilized aqueous liquid preparations of blood coagulation factor XIII Grant 6,084,074 - Kato , et al. July 4, 2 | 2000-07-04 |
| Method for the quantification of activated coagulation factor VII (FVIIa) Grant 5,968,759 - Romisch , et al. October 19, 1 | 1999-10-19 |
| NCAGE Code | 9V13A | CENTEON PHARMA GMBH |
| CAGE Code | 9V13A | CENTEON PHARMA GMBH |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 